Nueterra Capital

What Nueterra Capital does

Nueterra Capital is a privately-held, family-controlled venture capital firm founded in 1997 by Dan Tasset and headquartered in Leawood, Kansas, with a secondary office in Dallas, Texas. The firm invests in early-stage healthcare and technology companies past proof-of-concept with a 3–5 year path to strategic exit, targeting six core areas: digital health, AI applications, medical devices and diagnostics, consumer health, information technology/software solutions, and healthcare services. Its investment thesis is differentiated by a deliberate geographic focus on U.S. Emerging Markets (26+ states, 191 million population, $13T GDP) rather than coastal innovation hubs, and by a value-add operating model in which portfolio companies can pilot solutions inside Nueterra's network of 150+ managed surgery centers nationwide.

The firm operates a multi-fund platform (Fund I–IV) with $850M+ cumulatively deployed, $4.5B in portfolio value created, $3B distributed to limited partners, 50+ portfolio exits, and a 31% gross IRR on the latest healthcare venture fund — including one portfolio company valued at over $1B. Revenue mechanics follow the standard VC model of management fees on committed capital (estimated ~2% annually) supplemented by performance-based carried interest, with additional operating-company revenue from the surgery center platform. The 10+ professional team is led by Chairman Dan Tasset, CEO Jeremy Tasset, Managing Director Emmanuel Emah-Emeni (digital health lead, joined 2021), SVP George Lester, and Investment Partners Travis and Brandon Tasset, providing multi-generational continuity.

Go-to-market relies on direct investment relationships, portfolio referrals, and inbound deal flow through the firm's "Pitch Your Startup" funnel, supported by a news/blog channel and newsletter subscription. The 2026 launch of Fountain Health Partners (Boston/Kansas City), backed by Nueterra Capital, extends the firm's deal-sourcing footprint into co-investment partnerships. Solventas Foundation, established in 2014 as a wholly-owned nonprofit, manages philanthropic activities across community, education, and veteran-support causes, complementing the commercial investment platform.

Name

Nueterra Capital

Legal name

Nueterra Capital

Website

https://nueterra.com

Company type

Private

Founded year

1997

Operating status

Operating

Headcount range

11–50 employees

Short description

Nueterra Capital is a privately-held, family-controlled venture capital firm founded in 1997 that invests in early-stage healthcare and technology companies across U.S. Emerging Markets, leveraging operational expertise from 150+ managed surgery centers and a multi-fund platform.

Ownership category

akta.pro rank

Product category

Healthcare Venture Capital

NAICS

Portfolio Management and Investment Advice (523940)

SIC

Investment Advice (6282)

akta.pro industry

PRIMARYFSANAAAD

Sector-Focused Venture Capital (Vertical Specialists)

Financial & Insurance/Private Equity & Venture Capital/Venture Capital Firms

Keywords

• Venture capital
• Healthcare investments
• Private equity
• Early stage funding
• Growth capital

Headquarters

HQ city

Leawood

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Others

Revenue model

1. Management Fees: Standard VC management fees charged on committed capital under management across multiple fund vehicles (Fund I, II, III, IV).
2. Carried Interest: Performance-based carried interest from successful portfolio company exits. Latest healthcare venture fund generated gross IRR of 31% with distributions to investors of $3 billion.

Go-to-market motion2 records

Distribution channels1 record

Marketing channels3 records

Core offering

Nueterra Capital is a privately-held venture capital firm that deploys equity capital into early-stage healthcare and technology companies, primarily those located within U.S. Emerging Markets. The firm manages a series of healthcare-focused venture funds (Fund I through Fund IV) and provides strategic partnership, operational support, and pilot opportunities to portfolio companies through its existing infrastructure of operating healthcare businesses. Investment focus areas include digital health, AI applications, medical devices, diagnostics, concierge medicine, consumer health, and information technology solutions aimed at improving healthcare administration, diagnosis, and delivery.

Product overview

Nueterra Capital is a Midwest-based venture capital firm specializing in early-stage healthcare and technology companies. The firm focuses on investing in companies located within U.S. Emerging Markets that address inefficiencies in the administration, diagnosis, and delivery of healthcare. As an investment firm, Nueterra Capital does not offer traditional software products or services; rather, it provides capital and strategic support to portfolio companies operating across healthcare and technology sectors, including areas such as concierge medicine, device and diagnostics, digital and consumer health, artificial intelligence applications, and information technology solutions.

Differentiator

Problem solved

Functional benefit

Products and services

• Healthcare Venture Capital Funds (Fund I, II, III, IV)

Quantifiable outcome

• 31% gross IRR on latest healthcare venture fund
• +5 more outcomes

Named customers7 records

Segments4 records

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature2 records

Partnerships

Five partnerships are on record, tiered core and minor.

• Solventas FoundationcoreOthersFoundation established in 2014 by Nueterra Capital to assist organizations helping men, women, or children in need of strengthening mental, emotional, physical, spiritual and social capacity. Achieves goals by providing resources and leadership to help under-resourced communities.
• Hope Faith MinistriesminorOthersPartner organization of Solventas Foundation sharing the love of Christ by providing basic human needs including food, clothing, medical and social service intervention. Focuses on facilitating self-sufficient and independent living.
• Perspectives AcademyminorOthersEducational organization helping students who have struggled in traditional settings. Works with parents and school districts to provide structured learning supporting students academically, emotionally and socially. Accepts students grades 3-12.
• Sportsmen for HeroesminorOthersOrganization sharing love for fun, family, and outdoors by funding disabled veterans on hunting and fishing trips they would never be able to experience due to financial or physical limitations.
• NueHealth Surgical AllianceminorOthersU.S.-based nonprofit building local surgical access and capacity, creating self-sustaining surgical practices and improving access to lifesaving procedures in low and lower-middle income countries.

Scale indicators13 records

Recent moves6 records

Expansion highlights3 records

Broad incumbents

• General Catalyst: Large multi-stage venture firm with a dedicated healthcare practice (General Catalyst Health) investing across digital health, biotech, and care delivery. Comparable as a healthcare-focused growth investor, though materially larger AUM and broader sector coverage than Nueterra.
• Khosla Ventures: Long-established venture firm with significant healthcare and digital health exposure across early-stage and growth stages. Comparable healthcare thesis and stage focus, though broader sector mandate and West Coast concentration.
• Andreessen Horowitz (a16z Bio + Health): Mega-fund with a dedicated a16z Bio + Health practice investing across digital health, biotech, and care delivery. Comparable healthcare focus, though with much larger fund sizes and broader geographic mandate than Nueterra.
• New Enterprise Associates (NEA): Established multi-stage firm with a long-standing healthcare practice spanning medical devices, digital health, and services. Comparable stage and sector focus, with substantially larger AUM and longer institutional track record.

Direct peers

• OrbiMed: Dedicated healthcare-focused investment firm across venture, growth, and public equities. Closely comparable sector specialization and stage focus on healthcare innovation, with similar thesis of backing transformative healthcare businesses.
• ARCH Venture Partners: Pure-play healthcare/tech venture firm backing early-stage biotech, devices, and digital health. Comparable healthcare-specialist strategy and early-stage focus, with deeper biotech concentration.
• Foresite Capital: Healthcare-focused investment firm backing therapeutics, medical devices, and digital health across stages. Highly comparable vertical-specialist model with similar sector mandate and LP base orientation.
• Health Velocity Capital: Dedicated healthcare-focused growth equity firm investing in healthcare services, digital health, and life sciences. Comparable sector concentration and stage overlap, though oriented more toward growth than Nueterra's earlier-stage bias.
• Echo Health Ventures: Strategic healthcare venture partnership investing in early- and growth-stage healthcare companies across digital health, care delivery, and services. Comparable healthcare-specialist mandate and provider/payer strategic orientation.

Emerging players

• Heritage Provider Network (Heritage Group): Provider-backed strategic investment arm with healthcare venture exposure. Comparable operator-backed model leveraging healthcare delivery infrastructure for deal sourcing and validation, similar in concept to Nueterra's surgery center advantage.

Market position

Strengths1 record

Weaknesses1 record

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/Nueterra
• LinkedInlinkedin.com/company/146886

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments14 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Nueterra Capital